Friday, January 13, 2006
Second Texas Vioxx trial slated for January
Second Texas Vioxx trial slated for January
Reuters - USA
NEW YORK (Reuters) - Merck & Co. (MRK.N: Quote, Profile, Research), which lost its first Vioxx product liability case last summer in Texas, on Tuesday said a ...Drugs in '05: Much Promise, Little Payoff
New York Times - United States
... industry executives to complain that the FDA is denying approval to good new treatments because of the criticism the agency has faced from lawmakers over Vioxx ...
Second Texas Vioxx Trial to Start Jan. 24
FOX News - USA
NEW YORK -- Merck & Co. (MRK), which lost its first Vioxx product liability case last summer in Texas, Tuesday said a trial involving another Texas Vioxx user ...VIOXX(R) Trial Update: Statement on VIOXX(R) Product Liability ...
Genetic Engineering News - Larchmont,NY,USA
... The company believes the evidence in this case will show that VIOXX did not cause the unfortunate heart attack of Leonel Garza, Sr. ...
Fourth Vioxx Trial Set for The Valley
Texas Lawyer (subscription) - TX,USA
A jury in the Rio Grande Valley in Texas, a traditionally plaintiff-friendly location, will hear the nation's next Vioxx suit. The ...
Fourth Vioxx case set for Jan. 24
CNN/Money - USA
New Vioxx case to be held in Texas, while mistrial will be retried next month in New Orleans. By Aaron Smith, CNNMoney.com staff writer. ...
VIOXX(R) Trial Update: Statement on VIOXX(R) Product Liability ...
Finanzen.net - Germany
... years of cardiovascular disease and a prior heart attack.Approximately one month before his death, Mr. Garza was given aone-week supply of VIOXX 25 mg samples ...Stocks Rise Despite Smaller Intel Forecast
Newsday - Long Island,NY,USA
... of Medicine on Thursday said researchers failed to disclose that three patients suffered heart attacks in a 2000 Merck-funded study of its Vioxx painkiller. ...
The family business
Scientist - UK
Merck owes its victory in a recently concluded Vioxx trial in New Jersey largely to the testimony of J. Michael Gaziano, a Harvard cardiologist who expressed ...
Pharma's year of trouble and strife
Nature.com (subscription) - London,England,UK
The year began, much as 2004 had ended, with Vioxx (rofecoxib; Merck) and the other cyclooxygenase-2 (COX2) inhibitors dominating the headlines. ...Larry Sobal column: There's a mess beyond Vioxx
Appleton Post Crescent - WI, USA
Last month, it was all over the news that a US federal judge in Houston ruled that the latest trial involving Vioxx was a mistrial due to a hung jury. ...
Merck witness has chink in armor
Newark Star Ledger - Newark,NJ,USA
... Described by her bosses at the New Jersey pharmaceutical company as a "tenacious defender of the Vioxx franchise," she has been Merck's most reliable witness ...
